Phreesia, Inc. (NYSE:PHR) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have earned an average rating of “Moderate Buy” from the fifteen research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and fourteen have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $33.8571.

A number of analysts have recently weighed in on the stock. DA Davidson upped their price target on shares of Phreesia from $33.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 2nd. Raymond James Financial set a $33.00 target price on Phreesia and gave the stock an “outperform” rating in a research note on Friday, September 5th. BMO Capital Markets began coverage on Phreesia in a report on Thursday, November 13th. They issued an “outperform” rating and a $32.00 target price on the stock. Canaccord Genuity Group upped their price objective on Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, September 5th. Finally, Needham & Company LLC raised their price objective on Phreesia from $29.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, September 5th.

Insider Buying and Selling

In other Phreesia news, insider Evan Roberts sold 1,888 shares of the firm’s stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $22.36, for a total value of $42,215.68. Following the sale, the insider owned 724,949 shares in the company, valued at $16,209,859.64. This trade represents a 0.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, General Counsel Allison C. Hoffman sold 1,241 shares of the business’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $22.36, for a total transaction of $27,748.76. Following the sale, the general counsel directly owned 135,737 shares in the company, valued at approximately $3,035,079.32. The trade was a 0.91% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 26,174 shares of company stock worth $603,835 in the last quarter. Corporate insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Phreesia

Several hedge funds have recently modified their holdings of the company. Federated Hermes Inc. acquired a new position in Phreesia in the 3rd quarter worth about $32,000. Asset Management One Co. Ltd. acquired a new position in shares of Phreesia in the third quarter valued at approximately $45,000. State of Alaska Department of Revenue bought a new position in Phreesia in the 3rd quarter valued at approximately $83,000. Farther Finance Advisors LLC raised its holdings in Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after buying an additional 3,000 shares during the last quarter. Finally, Anchor Investment Management LLC acquired a new stake in Phreesia during the 3rd quarter worth approximately $118,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Stock Performance

PHR opened at $20.26 on Friday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12. Phreesia has a 52-week low of $18.55 and a 52-week high of $32.76. The firm has a market cap of $1.21 billion, a P/E ratio of -48.24 and a beta of 0.64. The business’s fifty day moving average is $22.09 and its 200-day moving average is $25.27.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.08. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. The business had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. During the same quarter in the prior year, the business posted ($0.03) earnings per share. Phreesia’s revenue was up 14.9% compared to the same quarter last year. Sell-side analysts expect that Phreesia will post -1.1 EPS for the current fiscal year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.